No beneficial effects of isocolloidoosmotic synthetic colloid addition to St. Thomas Hospital cardioplegic solution in ischemia-reperfusion injury in isolated perfused rat hearts

General Pharmacology

Volumn 32, Issue 1, 1999, Pages 101-105

  Süzer, Öner ^a   Köseoglu, Sabahat ^a   Han, Gülay ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Dexstrans; Gelatins; Hydroxyethyl starch; St. Thomas Hospital cardioplegic solution

Indexed keywords

CARDIOPLEGIC AGENT; CREATINE KINASE; DEXTRAN; DEXTRAN 70; GELATIN; GELATIN SUCCINATE; HEPARIN; HETASTARCH; ISOHES; LACTATE DEHYDROGENASE; PLASMA SUBSTITUTE; ST THOMAS HOSPITAL SOLUTION; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COLLOID; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; BICARBONATES; CALCIUM CHLORIDE; CARDIOPLEGIC SOLUTIONS; COLLOIDS; FEMALE; MAGNESIUM; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; PERFUSION; PLASMA SUBSTITUTES; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; SODIUM CHLORIDE;

EID: 0344936091     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00091-3     Document Type: Article

References (20)

1. Albes M., Baumgartel I., Rohde R., Hausen B., Demertzis S., Wahlers T. Influence of dextrans on cardiac preservation in an extracorporeal rat heart model. Eur. Surg. Res. 27:1985;406-410.
2. Assad-Morell J.D., Wallace R.B., Elveback L.R., Gau G.T., Connoly D.C., Barnhorst D.A., Pluth J.R., Danielson G.K. Serum enzyme data in diagnosis of myocardial infarction during or early after aorta-coronary saphenous vein bypass graft operations. J. Thorac. Cardiovasc. Surg. 69:1975;851.
3. Beards S.C., Watts T., Edwards J.D., Nightingale P., Faragner E.B. Comparison of the hemodynamic and oxygen transport responses to modified fluid gelatin and hetastarch in critically ill patients. A randomized trial Crit. Care. Med. 22:1981;600-605.
4. Bethencourt D.M., Laks H. Importance of edema and compliance changes during 24 hours of preservation of the dog heart. J. Thorac. Cardiovasc. Surg. 81:1981;440-449.
5. Beyer R., Harmening U., Rittmeyer O., Zielmann S., Mielck F., Katzmaier S., Kettler D. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br. J. Anaesth. 78:1997;44-50.
6. Brewer D.L., Bilbro R.H., Bartel A.G. Myocardial infarction as a complication of coronary bypass surgery. Circulation. 47:1973;58.
7. Brown J.M., Grosso M.A., Moore E.E. Hypertonic saline and dextran impact on cardiac function in the saline isolated rat heart. J. Trauma. 30:1990;646-650.
8. Drewnowska K., Clemo H.F., Baumgarten C.M. Prevention of myocardial intracellular edema induced by St. Thomas' Hospital cardioplegic solution. J. Mol. Cell. Cardiol. 23:1991;1215-1221.
9. Gürbüz A., Berki T., Akinci E., Koçak T., Yakut C. Hydroxyethyl starch (HES) as a priming solution in cardiopulmonary bypass. Vasc. Surg. 25:1991;308-314.
10. Hsu D.T., Weng Z.C., Nicolosi A.C., Detwiler P.W., Sciacca R., Spotnitz H.M. Quantitative effects of myocardial edema on the left ventricular pressure-volume relation. Influence of cardioplegia osmolarity over two hours of ischemic arrest. J. Thorac. Cardiovasc. Surg. 106:1993;651-657.
11. Iwasaki S., Araki H., Miyauchi Y., Nishi K. 24-hour preservation of isolated rat hearts perfused with pyridoxalated hemoglobin polyoxyethylene conjugate (PHP) solution at low temperature. Artif. Org. 5:1991;78-85.
12. Kirklin J.W., Barrat-Boyes B.G. Myocardial protection during cardiac surgery with cardiopulmonary bypass. Kirklin J.W., Barrat-Boyes B.G. Cardiac Surgery. 1986;83-108 John Wiley & Sons, New York.
13. Menasche P., Pradier F., Grousset C., Peynet J., Mouas C., Bloch G., Piwnica A. Improved recovery of heart transplants with a specific kit of preservation solutions. J. Thorac. Cardiovasc. Surg. 105:1993;353-363.
14. Okado T. Effect of dextran on the stability of isolated perfused rat heart. Jpn. J. Physiol. 39:1989;943-948.
15. Oz M. C., Zikria B. A., McLeod P. F., Fitzpatrick M. F., Duran W. N. and King C. T. (1989) Hydroxyethyl starch macromolecules protect against increases in microvascular permeability following ischemia-reperfusion injury. Am. Coll. Surg. Surgi. Forum XL, 48-50.
16. Shoemaker W.C. Comparison of the relative effectiveness of whole blood transfusions and various types of fluid therapy in resuscitation. Crit. Care Med. 4:1976;71-78.
17. Süzer Ö., Diri E., Konukoglu D., Özüner Z. The role of isocolloidoosmotic synthetic colloid addition to St. Thomas Hospital cardioplegic solution for cardioprotection in isolated perfused rat hearts. Pharmac. Res. 36:1997;9-15.
18. Süzer Ö., Köseoglu S., Özüner Z. Human albumin enriched St. Thomas Hospital cardioplegic solution increases reperfusion injury in isolated perfused rat hearts. Pharmac. Res. 37:1998;97-101.
19. Zikria A.B. Reduction of ischemia-reperfusion injury of myocardium by hydroxyethylstarch macromolecules. Circulation. 78(suppl II):1988;II-80.
20. Zikria A.B., Subbbarao C., Oz M., Shih S.T., McLeod P.F., Sachdev R., Freeman H.P., Hardy M.A. Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury. Crit. Care Med. 17:1989;1306-1309.